NIVABUPA vs PIRAMALFIN: Stock Comparison

NIVA BUPA HEALTH INS CO L vs PIRAMAL FINANCEUpdated 2 Sept 26, 4:08 PM ISTNSE & company filings

PIRAMAL FINANCE is the larger company by market capitalisation. NIVA BUPA HEALTH INS CO L shows faster revenue growth, while PIRAMAL FINANCE shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NIVABUPA leads 2; PIRAMALFIN leads 7 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NIVABUPAPIRAMALFIN

Valuation lens

What price are you paying?

Market CapContext only
₹14,923 Cr
₹49,869 Cr
P/E RatioPIRAMALFIN has the lower reading
116.18x
29.97x
P/B RatioPIRAMALFIN has the lower reading
4x
1.8x
EPSPIRAMALFIN has the higher reading
₹1.87
₹20.25
Book ValueContext only
₹23.73
₹1,243.68
Dividend YieldPIRAMALFIN has the higher reading
0%
0.48%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PIRAMALFIN is the larger company
₹49,869 Cr vs ₹14,923 Cr
P/E Ratio
PIRAMALFIN has a lower P/E
29.97x vs 116.18x
P/B Ratio
PIRAMALFIN has a lower P/B
1.8x vs 4x
EPS
PIRAMALFIN has higher earnings per share
₹20.25 vs ₹1.87
Dividend Yield
PIRAMALFIN has a higher dividend yield
0.48% vs 0%
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
ROE
PIRAMALFIN has a higher ROE
5.42% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNIVABUPAPIRAMALFIN
SectorFinancial Services
IndustryGeneral Insurance

Price

MetricNIVABUPAPIRAMALFIN
Live Price₹80.73₹2,186.5
Day Change-1.91%-1.78%
Volume3.66 L5.89 L
52-Week High₹91.4₹2,324
52-Week Low₹67.5₹1,416.5
Distance from 52W High-11.67%-5.92%

Valuation

MetricNIVABUPAPIRAMALFIN
Market Cap₹14,923 Cr₹49,869 Cr
P/E Ratio116.18x29.97x
P/B Ratio4x1.8x
EPS₹1.87₹20.25
Book Value₹23.73₹1,243.68
Dividend Yield0%0.48%

Growth

MetricNIVABUPAPIRAMALFIN
Revenue Growth (TTM YoY)26.8%0%
EPS Growth (TTM YoY)90.2%0%
Qtr Sales Growth-1.22%
Qtr Profit Growth4.79%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricNIVABUPAPIRAMALFIN
ROE0%5.42%
ROCE0%10.69%
Net Margin4.34%12.71%
Operating Margin58.08%
Debt to Equity0.07x1.65x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNIVABUPAPIRAMALFIN
Promoter Holding0%46.16%
FII Holding12.09% 1.49 pp15.45% 0.82 pp
DII Holding16.17% 0.32 pp18.63% 0.18 pp
Public Holding16.44% 1.11 pp19.54% 0.56 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NIVA BUPA HEALTH INS CO L and PIRAMAL FINANCE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.